Francesca Cerreta

2.4k total citations
19 papers, 337 citations indexed

About

Francesca Cerreta is a scholar working on Economics and Econometrics, Geriatrics and Gerontology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Francesca Cerreta has authored 19 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Economics and Econometrics, 8 papers in Geriatrics and Gerontology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Francesca Cerreta's work include Health Systems, Economic Evaluations, Quality of Life (15 papers), Pharmaceutical Practices and Patient Outcomes (7 papers) and Pharmaceutical studies and practices (6 papers). Francesca Cerreta is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (15 papers), Pharmaceutical Practices and Patient Outcomes (7 papers) and Pharmaceutical studies and practices (6 papers). Francesca Cerreta collaborates with scholars based in Netherlands, United Kingdom and Switzerland. Francesca Cerreta's co-authors include Hans‐Georg Eichler, Guido Rasi, Katarina Vučić, Armin Ritzhaupt, Laurent Servais, Scott Askin, Linda Lowes, Spiros Vamvakas, Craig M. McDonald and Sven Stegemann and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Nature Reviews Drug Discovery.

In The Last Decade

Francesca Cerreta

19 papers receiving 327 citations

Peers

Francesca Cerreta

PHYSI

PPCH

GHP

Sohyun Jeong United States

Mark Aagren United States

Jaana Isojärvi Finland

Michele Tari Italy

Mikkel Zöllner Ankarfeldt Denmark

Anette Lampert Germany

Clara Fitzgerald United States

Suja Abraham India

Gregory Steinberg United States

Aodán Tynan Ireland

Sohyun Jeong United States

Francesca Cerreta

66 ×0.5

84 ×0.7

57 ×1.2

PHYSI

24 ×0.6

PPCH

14 ×0.4

GHP

Citations per year, relative to Francesca Cerreta Francesca Cerreta (= 1×) peers Sohyun Jeong

Countries citing papers authored by Francesca Cerreta

Since Specialization

Citations

This map shows the geographic impact of Francesca Cerreta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Cerreta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Cerreta more than expected).

Fields of papers citing papers by Francesca Cerreta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Cerreta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Cerreta. The network helps show where Francesca Cerreta may publish in the future.

Co-authorship network of co-authors of Francesca Cerreta

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Cerreta. A scholar is included among the top collaborators of Francesca Cerreta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Cerreta. Francesca Cerreta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Cerreta, Francesca, Bruno Sepodes, Elina Rönnemaa, et al.. (2024). Medicines for an aging population: The EMA perspective and policies. Journal of the American Geriatrics Society. 72(9). 2921–2927. 3 indexed citations

Vetter, Thorsten, Jan Regnström, Maria Tome, et al.. (2023). Patient‐reported, observer‐reported and performance outcomes in qualification procedures at the European Medicines Agency 2013–2018. British Journal of Clinical Pharmacology. 90(1). 299–312. 2 indexed citations

Askin, Scott, Shibeshih Belachew, Timothy Kilchenmann, et al.. (2023). Evolving regulatory perspectives on digital health technologies for medicinal product development. npj Digital Medicine. 6(1). 56–56. 32 indexed citations

Riet‐Nales, Diana A. van, Bart J. F. van den Bemt, David van Bodegom, et al.. (2022). Commentary on the EMA reflection paper on the pharmaceutical development of medicines for use in the older population. British Journal of Clinical Pharmacology. 88(4). 1500–1514. 5 indexed citations

Cerreta, Francesca, Katarina Vučić, & Andrea Laslop. (2022). Assessing Medicines for Use in the Geriatric Population. Clinical Pharmacology & Therapeutics. 113(3). 536–540. 8 indexed citations

Servais, Laurent, et al.. (2021). First Regulatory Qualification of a Novel Digital Endpoint in Duchenne Muscular Dystrophy: A Multi-Stakeholder Perspective on the Impact for Patients and for Drug Development in Neuromuscular Diseases. SHILAP Revista de lepidopterología. 5(2). 183–190. 41 indexed citations

Cerreta, Francesca, et al.. (2020). Medication use among older people in Europe: Implications for regulatory assessment and co‐prescription of new medicines. British Journal of Clinical Pharmacology. 86(10). 1912–1920. 15 indexed citations

Cerreta, Francesca, et al.. (2020). Digital technologies for medicines: shaping a framework for success. Nature Reviews Drug Discovery. 19(9). 573–574. 32 indexed citations

Cerreta, Francesca, et al.. (2019). New harmonized considerations on the evaluation instruments for baseline characterization of frailty in the European Union. British Journal of Clinical Pharmacology. 86(10). 2017–2019. 5 indexed citations

10.

Eichler, Hans‐Georg, Richard Barker, Jacoline C. Bouvy, et al.. (2018). The evolution of adaptiveness: balancing speed and evidence. Nature Reviews Drug Discovery. 17(12). 845–846. 6 indexed citations

11.

Cerreta, Francesca, et al.. (2018). Medicines for older people: assessment and transparency at the European Medicines Agency regarding cardiovascular and antithrombotic medicinal products. European Geriatric Medicine. 9(4). 415–418. 5 indexed citations

12.

Eichler, Hans‐Georg, Mathieu Boudes, Jacoline C. Bouvy, et al.. (2018). Medicines Adaptive Pathways to Patients: Why, When, and How to Engage?. Clinical Pharmacology & Therapeutics. 105(5). 1148–1155. 7 indexed citations

13.

Raimi‐Abraham, Bahijja Tolulope, et al.. (2017). Regulatory considerations on the enrollment of older adults in oncology clinical trials. Journal of Geriatric Oncology. 8(3). 151–153. 3 indexed citations

14.

Cerreta, Francesca, Joël Ankri, David Bowen, et al.. (2016). BASELINE FRAILTY EVALUATION IN DRUG DEVELOPMENT. The Journal of Frailty & Aging. 5(3). 1–2. 8 indexed citations

15.

Riet‐Nales, Diana A. van, et al.. (2016). Regulatory incentives to ensure better medicines for older people: From ICH E7 to the EMA reflection paper on quality aspects. International Journal of Pharmaceutics. 512(2). 343–351. 20 indexed citations

16.

Vellas, Bruno, Roger A. Fielding, Shalender Bhasin, et al.. (2016). SARCOPENIA TRIALS IN SPECIFIC DISEASES: REPORT BY THE INTERNATIONAL CONFERENCE ON FRAILTY AND SARCOPENIA RESEARCH TASK FORCE. The Journal of Frailty & Aging. 1–7. 26 indexed citations

17.

Cerreta, Francesca, et al.. (2014). Regulatory activities to address the needs of older patients. The journal of nutrition health & aging. 19(2). 232–233. 9 indexed citations

18.

Cerreta, Francesca, Hans‐Georg Eichler, & Guido Rasi. (2012). Drug Policy for an Aging Population — The European Medicines Agency's Geriatric Medicines Strategy. New England Journal of Medicine. 367(21). 1972–1974. 92 indexed citations

19.

Stegemann, Sven, Jean‐Pierre Baeyens, Francesca Cerreta, et al.. (2012). Adherence measurement systems and technology for medications in older patient populations. European Geriatric Medicine. 3(4). 254–260. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact